U.S. Water Utilities Stock News

NasdaqGS:BNTX
NasdaqGS:BNTXBiotechs

US Stock Market Today: S&P 500 Futures Rise On Cooling Inflation And Housing Jitters

The Morning Bull - US Market Morning Update Thursday, Jan, 22 2026 US stock futures are pointing higher this morning, with key benchmarks like the E-mini S&P 500 and Nasdaq-100 futures up around 0.5% to 0.8%, as investors weigh cooling inflation signals against fresh signs of housing strain. The US PCE price gauge, a key Fed inflation yardstick, is seen rising 0.2% in November, with annual inflation projected at 2.8%, which suggests the cost of living is still rising but not at an aggressive...
NYSE:IT
NYSE:ITIT

Is Gartner (IT) Attractive After Recent Share Price Weakness?

If you are wondering whether Gartner's current share price still reflects the quality of the business, you are not alone. A closer look at its valuation can help frame that question more clearly. The stock last closed at US$232.44, with returns of a 2.7% decline over 7 days, 7.2% decline over 30 days, 1.9% decline year to date, 55.7% decline over 1 year and 29.3% decline over 3 years, while the 5 year return sits at 53.3%. Recent coverage of Gartner has focused on its role as a key research...
NasdaqGS:TYRA
NasdaqGS:TYRABiotechs

How Investors May Respond To Tyra Biosciences (TYRA) Strengthening Its Leadership Team And Regulatory Focus

Tyra Biosciences recently strengthened its leadership team by appointing Bhavesh Ashar as Chief Operating Officer and Heather Faulds as Chief Regulatory Officer, reinforcing its focus on developing precision medicines. These appointments, alongside growing attention on upcoming Phase 2 study readouts, have reinforced investor interest in how the company is positioning itself for its next phase of development. We’ll now examine how the expanded leadership bench, especially the new regulatory...
NasdaqGS:XP
NasdaqGS:XPCapital Markets

XP Inc. (XP) Valuation Check After Jefferies Buy Rating And Q3 Beat

XP (NasdaqGS:XP) drew fresh attention after Jefferies began coverage with a positive rating, alongside third quarter results that topped analyst expectations and new plans for a cash dividend and share repurchase program. See our latest analysis for XP. The latest moves fit into a strong recent run, with a 30 day share price return of 17.95% and an 18.17% year to date gain, while the 1 year total shareholder return of 59.87% contrasts with a negative 51.82% total shareholder return over five...
NasdaqCM:SIFY
NasdaqCM:SIFYTelecom

Sify Data Center IPO And Karnataka Facility Put Growth In Focus

Sify Technologies (NasdaqCM:SIFY) is pursuing an IPO for its data center subsidiary to fund expansion and refinance debt. The IPO plan is linked to strong demand in AI focused data center capacity. The company is preparing to inaugurate a new data centre facility in Karnataka as part of its digital infrastructure build out. Sify Technologies, trading at $14.63, has recorded a 1 year share price return of 350.2%, alongside a 23.0% return over the past 30 days and 19.1% year to date. These...
NYSE:PII
NYSE:PIILeisure

The Bull Case For Polaris (PII) Could Change Following Strong Quarter And Cautious 2026 Outlook – Learn Why

Polaris Inc. recently reported quarterly results showing revenue and earnings ahead of analyst expectations, even as long-serving director Kevin M. Farr announced his resignation as Audit Committee Chair effective January 14, 2026. At the same time, Polaris paired this operational momentum, including continued motorsport success at the 2026 Dakar Rally, with full-year guidance that was more cautious than that of its leisure-products peers. Next, we’ll examine how Polaris’ strong quarter but...
NasdaqCM:TGTX
NasdaqCM:TGTXBiotechs

Why TG Therapeutics (TGTX) Is Up 6.9% After Issuing 2026 BRIUMVI-Centric Revenue Guidance And What's Next

TG Therapeutics recently reported preliminary results indicating BRIUMVI U.S. net product revenue of about US$182 million for the fourth quarter of 2025 and approximately US$594 million for the full year, contributing to an estimated US$616 million in total global 2025 revenue. The company also issued 2026 guidance targeting about US$875–900 million in global revenue, with BRIUMVI U.S. net product revenue expected to account for roughly US$825–850 million, underscoring how central this...
NYSE:DBRG
NYSE:DBRGCapital Markets

Is It Too Late To Consider DigitalBridge Group (DBRG) After Its Recent Share Price Surge

If you are wondering whether DigitalBridge Group is priced attractively or starting to look stretched, the recent share performance gives you some useful clues before we talk numbers. The stock last closed at US$15.34, with a 17.7% gain over 30 days, a 34.3% return over the past year, a 19.2% return over three years, and a 12.5% decline over five years, while year to date it is roughly flat with a 0.3% decline. Recent news around DigitalBridge Group has focused on its position as a...